Studies related to Cognitive Decline and Ginkgo biloba

Efficacy And Tolerability Of A Once Daily Formulation Of Ginkgo Biloba Extract EGb 761® In Alzheimer's Disease And Vascular Dementia: Results From A Randomised Controlled Trial

Effect Decrease
Trial Design Double blind
Trial Length 1-6 months
Number of Subjects 404
Sex Both Genders
Age Range 45-64, 65+
Notes for this study:
24 weeks of supplementation with a 240mg EGb-761 formulation of ginkgo is able to improve cognitive and neuropsychiatric symptoms in persons with dementia (Alzheimer's and vascular origin).

Full details on all 11 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.